drugset / Trial / NCT00275275
Pramipexole Conversion to Ropinirole Controlled Release (CR)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
A conversion study of Mirapex (pramipexole) to Requip (ropinirole) controlled release (CR) in patients with Parkinson's disease to determine the appropriate conversion ratio and side effects related to the drug.
Timeline
- Start
- 2006-01
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ropinirole | Small molecule | — | — |
| Background | Pramipexole | Unknown | — | — |